Discover how inflammation peptides are revolutionising our understanding of immune regulation, offering new avenues for ...

Atombeat and BioDuro have announced a strategic partnership to launch an AI-powered platform aimed at accelerating peptide ...

Peptides are a staple in skincare, but are they as effective for hair growth and retention? Read on for more information, ...

A new study from researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) reveals that ...

On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, ...

This platform aims to deliver high-quality cyclic peptides with faster timelines and better economy across a broad range of ...

BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery: Irvine, California Saturday, August 2, 2025, 16:00 Hrs [IST ...

A new study from researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) reveals that extremely simple peptides can mimic a biological process that protects ...

ProteinQure's PQ203, a novel peptide drug conjugate, gains FDA fast track designation for advanced triple-negative breast ...

Phase 2 topline data from Avail trial expected in Q3 2025. Topline results from the Phase 2 Avail trial of canvuparatide, a potential long-acting, once-weekly parathyroid hormone (PTH) peptide prodrug ...

NEW YORK – ProteinQure said on Thursday that the US Food and Drug Administration and Health Canada cleared it to begin a Phase I trial of its lead candidate, the peptide-drug conjugate PQ203, in ...